A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01)
Patent
CA 2614046
The properties of an Fc-containing protein, for example, an antibody, are controlled by altering the sialylation of the oligosaccharides in the Fc region. The modified Fc-containing proteins have therapeutic utility in diseases or conditions in which it is desirable to control the affinity for one or more of the FcgRI, FcgRIIA, and FcgRIIIA receptors, ADCC activity, macrophage or monocyte activation, serum half-life, and avidity.
Les propriétés d'une protéine contenant un Fc, par exemple, un anticorps, sont maîtrisées par modification de la sialylation des oligosaccharides dans la région Fc. Le protéines contenant le Fc modifié présentent une utilité thérapeutique dans les maladies ou les états pathologiques où il est souhaitable de maîtriser l'affinité pour au moins l'un des récepteurs FcgRI, FcgRIIA, et FcgRIIIA, l'activité ADCC, l'activation des macrophages ou monocytes, la demi-vie sérique, ainsi que l'avidité.
Cai Ann
Ngo Cam
Raju T. Shantha
Scallon Bernard
Centocor Inc.
Centocor Ortho Biotech Inc.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Methods and compositions with enhanced therapeutic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions with enhanced therapeutic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions with enhanced therapeutic activity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2004337